EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Towards identification of novel inhibitors of EGFR mutants through in-silico approach

Pallavi Khodlan, Rajdeep Chakraborty, Tabarak Malik, Maninder Pal Singh, Priyanka Rajbhar, Praveen Kumar, Raj Kumar, Anand Mohan, Anil Kumar

Cancer Treatment and Research Communications · 2026 · 47 · 101179

DOI: 10.1016/j.ctarc.2026.101179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Pallavi Khodlan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gene Regulation Laboratory, National Institute of Immunology, New Delhi, India. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors, Antineoplastic Agents, Neoplasms. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Immunology, Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Kinase InhibitorsAntineoplastic AgentsNeoplasmsHumansErbB ReceptorsMolecular Docking SimulationMutationComputer Simulation

Stichwörter der Autor:innen

Anti-EGFR inhibitorsCancerIn silico pharmacokineticsMolecular docking

Substanzen

ErbB ReceptorsProtein Kinase InhibitorsEGFR protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Gene Regulation Laboratory, National Institute of Immunology, New Delhi, India.
  • School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW, 2109, Australia.
  • Department of Life Sciences, Parul Institute of Applied Sciences, Parul University, Vadodara, Gujarat-391760, India; Department of Biomedical Sciences, Institute of Health, Jimma University, Jimma, Ethiopia.
  • University School of Pharmaceutical Sciences, Rayat Bahra Professional University, Hoshiarpur, Punjab 146101, India.
  • School of Biotechnology, Gautam Buddha University, Greater Noida, Uttar Pradesh, India.
  • Indira Gandhi National Open University, New Delhi, India.

Förderung

  • National Institute of Immunology
  • Indian Council of Medical Research

Zitieren

APA

Khodlan, P., Chakraborty, R., Malik, T., Singh, M. P., Rajbhar, P., Kumar, P., Kumar, R., Mohan, A., & Kumar, A. (2026). Towards identification of novel inhibitors of EGFR mutants through in-silico approach. Cancer Treatment and Research Communications, 47, 101179. https://doi.org/10.1016/j.ctarc.2026.101179

Vancouver

Khodlan P, Chakraborty R, Malik T, Singh MP, Rajbhar P, Kumar P, et al. Towards identification of novel inhibitors of EGFR mutants through in-silico approach. Cancer Treatment and Research Communications. 2026;47:101179. doi:10.1016/j.ctarc.2026.101179

BibTeX
@article{Khodlan2026,
  author = {Khodlan, Pallavi and Chakraborty, Rajdeep and Malik, Tabarak and Singh, Maninder Pal and Rajbhar, Priyanka and Kumar, Praveen and Kumar, Raj and Mohan, Anand and Kumar, Anil},
  title = {Towards identification of novel inhibitors of EGFR mutants through in-silico approach},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  volume = {47},
  pages = {101179},
  doi = {10.1016/j.ctarc.2026.101179}
}
Kostenlos starten →